Accelerated rTMS: Complexities and clinical translation
Abstract
Major depressive disorder (MDD) is a severe and commonly occurring psychiatric illness with a substantial proportion of patients failing to respond adequately to standard treatments, often referred to as treatment-resistant depression (TRD). Repetitive transcranial magnetic stimulation (rTMS) has been developed as a safe and clinically effective intervention for TRD and is now increasingly accessible in routine clinical settings [1]. Although rTMS produces meaningful antidepressant effects for many patients, the standard delivery schedule is time intensive and clinical response typically occurs gradually.
Fields of Study & Subjects
Transcranial Magnetic Stimulation Studies
Electroconvulsive Therapy Studies
Electromagnetic Fields and Biological Effects
Publication details
- Journal / source
- Brain stimulation
- Publisher
- Elsevier BV
- Volume
- 19
- Issue
- 2
- Pages
- 103057–103057
- Publication date
- 17 February 2026
- Language
- EN